Clinical Trials Directory

Trials / Completed

CompletedNCT05109533

Probiotics Role in HPV Cervico-vaginal Infection Clearance

Probiotics Role in HPV Clearance When Coexisting Vaginal Infections

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
483 (actual)
Sponsor
Azienda Ospedaliero, Universitaria Pisana · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Vaginal infections demonstrated to be implicated in the persistence of HPV, activating a vicious circle of vaginal microbial perturbations. HPV infection can destroy the biofilm barrier formed by the local vaginal immune microenvironment, leading to a condition called dysbiosis. Contemporarily, the resulting local microecological imbalance in the vagina can subsequently upregulate the expression of the HPV protein, increasing HPV-related cytological alterations.

Detailed description

A total of 483 women affected by different vaginal infections and concomitant HPV-positivity were enrolled between 2018 and 2020 at Department of Gynecological, Obstetrical and Urological Sciences, University "Sapienza" of Rome (Rome, Italy) and 2nd Division of Obstetrics and Gynecology, Azienda Ospedaliera Universitaria Pisana, University of Pisa (Pisa, Italy). Women with positive swabs for infections were randomized in two groups, standard specific treatment (n=231) versus the standard treatment plus long-lasting (9 months) vaginal and oral probiotics implementation (n=252).

Conditions

Interventions

TypeNameDescription
OTHERLactobacillus rhamnosus BMX 54, Lactobacillus reuteri RC-14, Lactobacillus rhamnosus GR-1Probiotics implementation

Timeline

Start date
2018-01-01
Primary completion
2020-12-31
Completion
2021-03-31
First posted
2021-11-05
Last updated
2021-11-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05109533. Inclusion in this directory is not an endorsement.